151 related articles for article (PubMed ID: 12064914)
41. Late Development of FcεRγ
Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
Front Immunol; 2018; 9():1050. PubMed ID: 29868012
[TBL] [Abstract][Full Text] [Related]
42. Comprehensive Analysis and Summary of the Value of Immunophenotypes of Mature NK Cell Tumors for Differential Diagnosis, Treatment, and Prognosis.
Pu Q; Cao X; Liu Y; Yan D; Tan R; Li J; Yue B
Front Immunol; 2022; 13():918487. PubMed ID: 35812422
[TBL] [Abstract][Full Text] [Related]
43. Differences in activation and tissue homing markers of natural killer cell subsets during acute dengue infection.
Keawvichit R; Khowawisetsut L; Lertjuthaporn S; Tangnararatchakit K; Apiwattanakul N; Yoksan S; Chuansumrit A; Chokephaibulkit K; Ansari AA; Onlamoon N; Pattanapanyasat K
Immunology; 2018 Apr; 153(4):455-465. PubMed ID: 29105052
[TBL] [Abstract][Full Text] [Related]
44. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.
Yagita M; Huang CL; Umehara H; Matsuo Y; Tabata R; Miyake M; Konaka Y; Takatsuki K
Leukemia; 2000 May; 14(5):922-30. PubMed ID: 10803526
[TBL] [Abstract][Full Text] [Related]
45. [Evaluation of the subsets of lymphocytes and their activated status in patients with myelodysplastic syndrome].
Yang J; Wang C; Xie KC; Yan SK; Gao YR; Cai Q; Qin YW; Wan LP; Cai Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):708-13. PubMed ID: 16928305
[TBL] [Abstract][Full Text] [Related]
46. Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.
Iriyama N; Asou N; Miyazaki Y; Yamaguchi S; Sato S; Sakura T; Maeda T; Handa H; Takahashi M; Ohtake S; Hatta Y; Sakamaki H; Honda S; Taki T; Taniwaki M; Miyawaki S; Ohnishi K; Kobayashi Y; Naoe T
Ann Hematol; 2014 Jun; 93(6):957-63. PubMed ID: 24441947
[TBL] [Abstract][Full Text] [Related]
47. Eight-color immunophenotyping of T-, B-, and NK-cell subpopulations for characterization of chronic immunodeficiencies.
Boldt A; Borte S; Fricke S; Kentouche K; Emmrich F; Borte M; Kahlenberg F; Sack U
Cytometry B Clin Cytom; 2014 May; 86(3):191-206. PubMed ID: 24488780
[TBL] [Abstract][Full Text] [Related]
48. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation.
Morandi F; Horenstein AL; Chillemi A; Quarona V; Chiesa S; Imperatori A; Zanellato S; Mortara L; Gattorno M; Pistoia V; Malavasi F
J Immunol; 2015 Aug; 195(3):965-72. PubMed ID: 26091716
[TBL] [Abstract][Full Text] [Related]
49. High correlations of anti-CMV titers with lymphocyte activation status and CD57 antibody-binding capacity as estimated with three-color, quantitative flow cytometry in blood donors.
Lenkei R; Andersson B
Clin Immunol Immunopathol; 1995 Nov; 77(2):131-8. PubMed ID: 7586720
[TBL] [Abstract][Full Text] [Related]
50. Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients.
Vlková M; Thon V; Sárfyová M; Bláha L; Svobodník A; Lokaj J; Litzman J
Clin Exp Immunol; 2006 Feb; 143(2):373-9. PubMed ID: 16412063
[TBL] [Abstract][Full Text] [Related]
51. Expression of CD45 isoforms by fresh and activated human gamma delta T lymphocytes and natural killer cells.
Braakman E; Sturm E; Vijverberg K; van Krimpen BA; Gratama JW; Bolhuis RL
Int Immunol; 1991 Jul; 3(7):691-7. PubMed ID: 1832950
[TBL] [Abstract][Full Text] [Related]
52. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
53. Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection.
Lieberman J; Trimble LA; Friedman RS; Lisziewicz J; Lori F; Shankar P; Jessen H
AIDS; 1999 May; 13(8):891-9. PubMed ID: 10371169
[TBL] [Abstract][Full Text] [Related]
54. Phenotypic switch from CD45RA+ to CD45RA- by normal blood T cells is associated with increased HLA-ABC expression for CD4+ and CD8+ populations but not for the NK-associated CD4-CD8dim+ or CD4-CD8- fractions.
Jones RA; Richards SJ; Roberts BE; Child JA; Scott CS
Immunology; 1990 May; 70(1):55-60. PubMed ID: 1972374
[TBL] [Abstract][Full Text] [Related]
55. Clonal CD3+CD8+ large granular lymphocyte (LGL)/NK-associated (NKa) expansions: primary malignancies or secondary reactive phenomena?
Richards SJ; Short M; Scott CS
Leuk Lymphoma; 1995 Apr; 17(3-4):303-11. PubMed ID: 8580800
[TBL] [Abstract][Full Text] [Related]
56. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
[TBL] [Abstract][Full Text] [Related]
57. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells.
Suzuki R; Suzumiya J; Nakamura S; Aoki S; Notoya A; Ozaki S; Gondo H; Hino N; Mori H; Sugimori H; Kawa K; Oshimi K;
Leukemia; 2004 Apr; 18(4):763-70. PubMed ID: 14961041
[TBL] [Abstract][Full Text] [Related]
58. Identification of natural killer (NK) cells in lesions of human cutaneous graft-versus-host disease: expression of a novel NK-associated surface antigen (Kp43) in mononuclear infiltrates.
Acevedo A; Aramburu J; López J; Fernández-Herrera J; Fernández-Rañada JM; López-Botet M
J Invest Dermatol; 1991 Oct; 97(4):659-66. PubMed ID: 1682391
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
Pricop L; Rabinowich H; Morel PA; Sulica A; Whiteside TL; Herberman RB
J Immunol; 1993 Sep; 151(6):3018-29. PubMed ID: 7690792
[TBL] [Abstract][Full Text] [Related]
60. Expression of an early myelopoietic antigen (CD33) on a subset of human umbilical cord blood-derived natural killer cells.
Handgretinger R; Schäfer HJ; Baur F; Frank D; Ottenlinger C; Bühring HJ; Niethammer D
Immunol Lett; 1993 Aug; 37(2-3):223-8. PubMed ID: 7505004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
